GRANULES INDIA LIMITED (GRANULES) financials
GRANULES INDIA LIMITED (GRANULES) NSE/BSE financials on Fincrux: quarterly results, profit and loss, cash flow, balance sheet, ratios, and shareholding.
Granules India Ltd and its subsidiaries are primarily involved in the manufacturing and selling of Active Pharma Ingredients (APIs), Pharmaceutical Formulation Intermediates (PFIs) and Finished Dosages.[1]
- Market Cap: ₹21,951Cr.
- Current Price: ₹803
- Stock P/E: 54.5
- ROE: 10.5%
- ROCE: 12.8%
- Book Value: ₹178
- Dividend Yield: 0.22%
- 52W High / Low: ₹924/520
In Jun 2026, GRANULES INDIA LIMITED (GRANULES) reported sales ₹802 Cr and net profit ₹72 Cr.
Annual TTM: sales ₹3,466 Cr, net profit ₹403 Cr.
Shareholding: Promoters 37.39% (Sep 2026), FIIs 20.25% (Sep 2026), DIIs 15.33% (Sep 2026), Public 27.04% (Sep 2026), No. of Shareholders 1,82,022% (Sep 2026).
| Category | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 568 | 842 | 768 | 810 | 892 | 895 | 877 | 802 |
| Expenses | 465 | 674 | 651 | 667 | 680 | 701 | 702 | 670 |
| Operating Profit | 103 | 168 | 117 | 144 | 211 | 194 | 175 | 131 |
| OPM % | 18% | 20% | 15% | 18% | 24% | 22% | 20% | 16% |
| Other Income | 3 | 6 | 61 | 1 | 8 | 12 | 17 | 14 |
| Interest | 15 | 17 | 13 | 14 | 17 | 15 | 16 | 10 |
| Depreciation | 35 | 38 | 38 | 40 | 41 | 41 | 44 | 39 |
| Profit before tax | 56 | 119 | 127 | 91 | 162 | 150 | 132 | 97 |
| Tax % | 26% | 24% | 26% | 24% | 26% | 26% | 25% | 26% |
| Net Profit | 41 | 90 | 94 | 69 | 121 | 112 | 99 | 72 |
| EPS in Rs | 1.71 | 3.72 | 3.88 | 2.86 | 4.97 | 4.60 | 3.99 | 2.90 |
| Raw PDF | — | — | — | — | — | — | — | — |
| Category | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|
| Sales | 2,310 | 3,135 | 3,238 | 3,931 | 3,755 | 3,030 | 3,474 | 3,466 |
| Expenses | 1,816 | 2,273 | 2,589 | 3,092 | 2,951 | 2,464 | 2,750 | 2,754 |
| Operating Profit | 494 | 862 | 649 | 840 | 804 | 567 | 724 | 712 |
| OPM % | 21% | 27% | 20% | 21% | 21% | 19% | 21% | 21% |
| Other Income | 187 | 13 | 13 | 9 | 3 | 70 | 38 | 50 |
| Interest | 27 | 24 | 16 | 39 | 72 | 63 | 61 | 57 |
| Depreciation | 102 | 118 | 126 | 146 | 144 | 146 | 164 | 164 |
| Profit before tax | 553 | 733 | 520 | 664 | 591 | 427 | 536 | 541 |
| Tax % | 20% | 25% | 26% | 25% | 26% | 25% | 25% | — |
| Net Profit | 444 | 553 | 387 | 499 | 436 | 319 | 401 | 403 |
| EPS in Rs | 17.47 | 22.32 | 15.59 | 20.61 | 17.99 | 13.17 | 16.17 | 16.46 |
| Dividend Payout % | 6% | 7% | 10% | 7% | 8% | 11% | 11% | — |
| Category | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Equity Capital | 25 | 25 | 25 | 25 | 24 | 24 | 24 | 25 |
| Reserves | 1,398 | 1,786 | 2,138 | 2,506 | 2,675 | 3,087 | 3,379 | 4,374 |
| Borrowings | 991 | 891 | 849 | 1,061 | 923 | 1,065 | 899 | 828 |
| Other Liabilities | 410 | 444 | 672 | 781 | 881 | 830 | 850 | 754 |
| Total Liabilities | 2,824 | 3,146 | 3,683 | 4,373 | 4,503 | 5,006 | 5,152 | 5,981 |
| Fixed Assets | 700 | 927 | 985 | 1,171 | 1,330 | 1,324 | 1,405 | 1,453 |
| CWIP | 333 | 130 | 164 | 211 | 63 | 53 | 121 | 118 |
| Investments | 506 | 445 | 592 | 597 | 677 | 941 | 1,282 | 2,030 |
| Other Assets | 1,285 | 1,644 | 1,942 | 2,395 | 2,433 | 2,688 | 2,345 | 2,381 |
| Total Assets | 2,824 | 3,146 | 3,683 | 4,373 | 4,503 | 5,006 | 5,152 | 5,981 |
| Category | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity | 227 | 495 | 375 | 280 | 664 | 317 | 823 | 643 |
| Cash from Investing Activity | -243 | -165 | -233 | -318 | -97 | -302 | -554 | -1,030 |
| Cash from Financing Activity | -17 | -212 | -296 | 151 | -519 | 26 | -340 | 444 |
| Net Cash Flow | -33 | 118 | -154 | 114 | 48 | 41 | -71 | 58 |
| Free Cash Flow | 39 | 376 | 152 | -43 | 452 | 198 | 618 | 404 |
| CFO/OP | 94% | 124% | 65% | 65% | 100% | 59% | 161% | 110% |
| Category | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 38.85% | 38.83% | 38.82% | 38.81% | 38.81% | 38.02% | 38.01% | 37.39% |
| FIIs | 15.87% | 15.14% | 13.24% | 14.09% | 13.55% | 15.31% | 17.50% | 20.25% |
| DIIs | 19.57% | 22.45% | 23.52% | 17.91% | 17.47% | 17.01% | 16.11% | 15.33% |
| Public | 25.71% | 23.56% | 24.41% | 29.17% | 30.15% | 29.67% | 28.36% | 27.04% |
| No. of Shareholders | 1,77,554 | 1,69,802 | 1,69,700 | 1,65,542 | 1,63,184 | 1,60,286 | 1,69,422 | 1,82,022 |
| Category | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Debtor Days | 122 | 99 | 118 | 136 | 127 | 159 | 156 | 131 |
| Inventory Days | 92 | 103 | 112 | 123 | 100 | 111 | 176 | 151 |
| Days Payable | 81 | 96 | 123 | 126 | 126 | 125 | 167 | 118 |
| Cash Conversion Cycle | 133 | 105 | 107 | 133 | 102 | 144 | 166 | 164 |
| Working Capital Days | 53 | 56 | 59 | 49 | 48 | 62 | 62 | 60 |
| ROCE % | 12% | 16% | 26% | 16% | 20% | 17% | 11% | 13% |
Granules India Limited
₹21,951Cr.
₹803
₹924/520
54.5
Granules India Ltd and its subsidiaries are primarily involved in the manufacturing and selling of Active Pharma Ingredients (APIs), Pharmaceutical Formulation Intermediates (PFIs) and Finished Dosages.[1]
Quarterly results
Profit & loss
Shareholding trend
Balance sheet
Cash flows
Key ratios
Frequently asked questions
What is the market cap of GRANULES INDIA LIMITED (GRANULES)?
The reported market capitalisation for GRANULES INDIA LIMITED (GRANULES) is ₹21,951Cr. on Fincrux. Figures may update with market data and filings.
What is the current share price of GRANULES?
The current price shown for GRANULES INDIA LIMITED (GRANULES) on Fincrux is ₹803 with a 52-week high/low of ₹924/520.
What is the P/E ratio of GRANULES INDIA LIMITED (GRANULES)?
The stock P/E for GRANULES INDIA LIMITED (GRANULES) is 54.5 on Fincrux, with ROE at 10.5% and ROCE at 12.8%.
What were GRANULES latest quarterly results?
For Jun 2026, GRANULES INDIA LIMITED (GRANULES) reported sales ₹802 Cr and net profit ₹72 Cr (figures in ₹ crore unless noted).
What are GRANULES annual sales and net profit?
For TTM, GRANULES INDIA LIMITED (GRANULES) shows sales of ₹3,466 Cr and net profit of ₹403 Cr on the Fincrux profit & loss statement.
Who owns GRANULES INDIA LIMITED (GRANULES)?
Latest shareholding for GRANULES INDIA LIMITED (GRANULES) on Fincrux: Promoters 37.39% (Sep 2026), FIIs 20.25% (Sep 2026), DIIs 15.33% (Sep 2026), Public 27.04% (Sep 2026), No. of Shareholders 1,82,022% (Sep 2026).
Where can I find GRANULES INDIA LIMITED (GRANULES) financials?
GRANULES INDIA LIMITED (GRANULES) financials on Fincrux include quarterly results, profit and loss, cash flow, balance sheet, key ratios, and shareholding patterns for NSE/BSE research.
Does Fincrux show GRANULES balance sheet and cash flow?
Yes. The GRANULES INDIA LIMITED (GRANULES) page on Fincrux includes balance sheet, cash flow statements, historical ratios, and ownership trends alongside quarterly and annual results.